This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DenMat Announces New Vice President Of International Sales

LOMPOC, Calif., Nov. 3, 2012 /PRNewswire/ -- DenMat is pleased to announce that Fabian Salaverry has joined the company as Vice President, International Sales. Most recently, Mr. Salaverry served as CEO of Swiss Medical Technology, a leading European manufacturer of aesthetic and medical devices.

"Fabian is an experienced professional with proven success in international sales and marketing in the dental device and aesthetic arenas," commented Shawn Potter, Sr. Vice President, Global Sales. "I am very pleased to welcome someone with Fabian's talent and experience to the DenMat's leadership team."

With over 17 years in the dental industry, Mr. Salaverry is fluent in six languages and earned an MBA from GSBA, Zurich.

"Fabian brings a proven track record in developing high growth strategies across multiple markets in industries where customer and distributor relationships are critical," continued Mr. Potter.

To contact Mr. Salaverry or DenMat, please call 805-922-8491 or visit www.DenMat.com.

Media Contact:    DenMat Holdings, LLC
    Carol Newberry, 805-922-8491 x2810, cnewberry@denmat.com



About DenMat

DenMat manufactures a broad range of cosmetic, restorative and clinical product solutions, available in the U.S. and over 68 countries worldwide. Ongoing partnerships continue to position DenMat in the forefront of the dental industry. LUMINEERS, the contact-lens thin veneers placed without the need for anesthetic, extensive prepping or temporaries, is the cornerstone of DenMat's Smile Portfolio, and the LUMINEERS Smile Design Studio is recognized as a leading laboratory for both minimally invasive and traditional-preparation restorations. DenMat also offers continuing education programs internationally, including Destination Education events held at resort locations across the U.S. For more information, call 800-433-6628 or visit www.denmat.com.

SOURCE DenMat Holdings, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,558.61 -39.59 -0.22%
S&P 500 2,096.71 -1.33 -0.06%
NASDAQ 5,108.3550 -7.0270 -0.14%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs